AIIMS to Begin Booster Trial of Bharat Biotech’s Intranasal Vaccine Today on Those Jabbed With Covaxin, Covishield
The All India Institute of Medical Sciences, Delhi (AIIMS) will start a booster dose trial of Indian firm Bharat Biotech’s […]
The All India Institute of Medical Sciences, Delhi (AIIMS) will start a booster dose trial of Indian firm Bharat Biotech’s […]
Serum Institute of India has sought permission from India’s drug regulator to conduct a phase-3 study of its COVID-19 vaccine
The Drugs Controller General Of India (DCGI) had approved Covovax for restricted use in emergency situations in adults on December
New Delhi: Bharat Biotech on Saturday said its Covaxin will be evaluated as a COVID-19 vaccine candidate in the US.
Covaxin   New Delhi: COVAXIN will be evaluated as a COVID-19 vaccine candidate in the United States. Making the
Fully vaccinated international passengers from 82 countries will be permitted quarantine-free entry from February 14, the Ministry of Health and
Data from human trials of India’s first homegrown mRNA COVID-19 vaccine are likely to be presented to authorities for evaluation
The country recorded 66,871 new COVID-19 cases on Wednesday. The total number of infections has reached 4.24 crore and active
The country recorded 71,550 new COVID-19 cases on Tuesday. The total number of infections has reached 4.23 crore, and the
The country recorded 65,513 new Covid-19 cases on Monday. The total number of infections has reached 4.22 crore, and the
The benefits of COVID-19 vaccine outweigh its known adverse reactions, and the recent reports on Adverse Events Following Immunisation (AEFI)
The country recorded 84,474 new COVID-19 cases on Sunday. The total number of infections has reached 4.22 crore, and the